| __timestamp | TG Therapeutics, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24518692 | 1244910 |
| Thursday, January 1, 2015 | 19886580 | 5029636 |
| Friday, January 1, 2016 | 12631689 | 4846776 |
| Sunday, January 1, 2017 | 21977998 | 5329003 |
| Monday, January 1, 2018 | 20759000 | 7121000 |
| Tuesday, January 1, 2019 | 20838000 | 9128000 |
| Wednesday, January 1, 2020 | 121812000 | 10731000 |
| Friday, January 1, 2021 | 152137000 | 10701000 |
| Saturday, January 1, 2022 | 83231000 | 16121000 |
| Sunday, January 1, 2023 | 122706000 | 37021000 |
Unleashing insights
In the competitive landscape of biotechnology, understanding the financial strategies of leading companies is crucial. Over the past decade, TG Therapeutics, Inc. and Viking Therapeutics, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. TG Therapeutics has consistently outpaced Viking Therapeutics, with its SG&A expenses peaking at approximately 152 million in 2021, a staggering 900% increase from 2014. In contrast, Viking Therapeutics' expenses grew more modestly, reaching around 37 million in 2023, marking a 2900% increase from its 2014 figures. This disparity highlights TG Therapeutics' aggressive investment in administrative and sales functions, potentially reflecting a more expansive growth strategy. As the biotech sector continues to evolve, these financial insights offer a window into the strategic priorities of these two industry players.
Breaking Down SG&A Expenses: Johnson & Johnson vs TG Therapeutics, Inc.
Novartis AG and Viking Therapeutics, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of argenx SE and Viking Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Viking Therapeutics, Inc.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and MorphoSys AG
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Viking Therapeutics, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Viking Therapeutics, Inc. and Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated